Home > PJ (current issue) > The Society / Daily News | Search

The Pharmaceutical Journal
Vol 272 No 7298 p585
8 May 2004


Society summary


Society issues guidance on raising financial questions at the AGM

The Royal Pharmaceutical Society has issued guidance for members who may have queries about the Society's financial statements for 2003. The guidance (see Panel below) makes it clear, as previously announced (PJ, 1 May, p554) that the Society cannot guarantee to provide answers to questions raised during the annual general meeting on 12 May unless the questions have been submitted well before the meeting.

The guidance also reminds members that, like the annual review, the financial statements are presented to the annual general meeting for information only and do not require the meeting’s approval.

Guidelines for the annual general meeting with regard to the financial statements

Over the past few weeks, and in line with the Society’s Byelaws, the 2003 accounts for the Society have been available to members on the Society’s website (www.rpsgb.org). A summary of the accounts also appeared in the Society’s annual review, which was distributed to all members on 1 May.

At the annual general meeting on Wednesday 12 May, the Treasurer, Linda Stone, the Director of Finance and Resources, Bernard Kelly, and the Financial Controller, Graham Duncan, will present the 2003 financial statements and auditors’ report to members. The presentation will give full details of the change in accounting policy and any significant items which have impacted the results during 2003.

The presentation of the 2003 financial statements to the members at the annual general meeting is for information only. It is the responsibility of the Council to approve the Society’s financial statements at its March meeting. The annual general meeting will therefore follow the procedure of 2003, under which members receive the accounts approved by Council and no vote is taken.

Members have the opportunity to raise any question in relation to the 2003 financial statements and are invited to submit questions by either e-mail to accounts2003@rpsbg.org or by post to Graham Duncan, Financial Controller, 1 Lambeth High Street, London SE1 7JN. Questions received by 7 May will be answered at the annual general meeting. Any question received after that date or raised at the AGM without prior notification may not be responded to at the meeting. These questions will be followed up, in writing, directly with the member.

Back to Top


©The Pharmaceutical Journal